Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression (Q33646478)

28 July 2017

Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression (English)

1 reference

28 July 2017

1 reference

1 reference

G L Daikos

1

1 reference

28 July 2017

J Pulido

series ordinal

2

1 reference

28 July 2017

S B Kathpalia

series ordinal

3

1 reference

28 July 2017

G G Jackson

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

British Journal of Ophthalmology

28 July 2017

1 reference

28 July 2017

72

1 reference

28 July 2017

7

1 reference

28 July 2017

521-524

1 reference

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Intraocular 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside

30 October 2018

1 reference

12 December 2020

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

12 December 2020

Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent

1 reference

12 December 2020

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

12 December 2020

BW B759U for cytomegalovirus retinitis: intraocular drug penetration

1 reference

12 December 2020

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

12 December 2020

9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.72.7.521

1 reference

28 July 2017

1 reference

28 July 2017

1 reference